A German venture capital firm functioning as a subsidiary of ATHOS Service
Santo Venture Capital GmbH is a German venture capital fundventure capital fund headquartered in Holzkirchen, Germany. It is a subsidiary of ATHOS Service, the family office of twin pharmaceutical executives Thomas and Andreas Strüngmann, founders of generic drug manufacturer Hexal AG. The firm was was founded in 2011.
Santo Venture Capital GmbH is a German venture capital fund headquartered in Holzkirchen, GermanyGermany. It is a subsidiary of ATHOS Service, the family office of twin pharmaceutical executives Thomas and Andreas Strüngmann, founders of generic drug manufacturer Hexal AG. The firm was was founded in 2011.
A German venture capital firm functioning as a subsidiary of ATHOS Service
Santo Venture Capital GmbH is a German venture capital fund headquartered in Holzkirchen, Germany. It is a subsidiary of ATHOS Service, the family office of twin pharmaceutical executives Thomas and Andreas Strüngmann, founders of generic drug manufacturer Hexal AG. The firm was was founded in 2011.
The fund invests in the healthcare, biopharmaceutical, energy, e-commerce, and logistics. It primarily makes Series A and later round fundings. Santo Venture Capital's average investment ranges from €5 million to €20 million.
A German venture capital firm functioning as a subsidiary of ATHOS Service